Centennial CE Program

Low-Dose Atropine for Myopia Control

Karla Zadnik, OD, PhD

Dean, Ohio State University College of Optometry

COPE Course 85504-GO: This lecture will present the current body of knowledge on studies using low-dose atropine for juvenile-onset myopia control. The initial studies from Asia, the Vyluma-sponsored CHAMP Study, and recent literature on compounded low-dose atropine will be discussed. You will learn about the efficacy of low-dose atropine around the world; the safety of low-dose atropine around the world; and current low-dose atropine prescribing trends.

Translational Studies in Ocular Biomechanics: From Theory to Practice

Michael Twa, OD, PhD

Dean, University of Houston College of Optometry

COPE Course 86089-TD: Ocular tissue biomechanics are an important factor in normal physiological function and diseases including myopia, glaucoma, keratoconus and others. This course will cover new developments in diagnostic imaging and their applications for clinical practice. Dr. Twa will introduce fundamental concepts in soft-tissue biomechanics and their importance in ocular disease, and will highlight the development and application of optical coherence elastography as a novel diagnostic imaging method for understanding how tissue properties are altered in disease and influenced by treatment.

Updates in Ocular Surface Disease

Kelly Nichols, OD, MPH, PHD, FAAO

Dean, University of Alabama at Birmingham School of Optometry

COPE Course 86088-TD: Ocular surface disease is highly prevalent and causes many patients to seek care and treatments due to symptoms of eye dryness and irritation. Emerging diagnostics and therapeutics should aid the clinician in earlier diagnosis and improved management. This lecture will prepare you to distinguish the burden of disease associated with DED, MGD-associated DED, and other ocular surface conditions; analyze new key trial data surrounding therapies used for the treatment of ocular surface diseases; recognize the mechanisms of action of emerging agents for the treatment for DED; and evaluate safety, efficacy, and key clinical trial data for emerging agents.

Alumni Grand Rounds

Harry Green, OD, PhD

Sam Lee, OD

Kristina Lin, OD

Angela Shahbazian, OD, FAAO

Herbert Wertheim School of Optometry and Vision Science

COPE Course 86090-TD: This two-hour grand rounds session featuring UC Berkeley School of Optometry alumni will include cases on nodular episcleritis, neurosyphilis, and more. Speakers will discuss case details, diagnostic testing, treatment options, systemic workup, and interdisciplinary management.

Bridging the Divide in Low Vision Rehabilitation – Leveraging Telehealth for New Models of Care

Stanley Woo, OD, MS, MBA, FAAO

Director, School of Optometry and Vision Science at the University of Waterloo

COPE Course 85570-LV: Teleoptometry is a tool to increase access to eye and vision care services. Different models may be applicable to specific areas of care including low vision rehabilitation. This course will enable learners to define teleoptometry within the telehealth space, and understand applications to increase access to care, compare and contrast models of care for low vision rehabilitation with teleoptometry, and critically evaluate opportunities for incorporating low vision rehabilitation into practice to serve their patients.

Learning to See in 3D

Dennis Levi, OD, PhD

Dean Emeritus, Herbert Wertheim School of Optometry and Vision Science

COPE Course 85293-FV: Stereopsis provides us with a vivid impression of the depth and distance of objects in our 3-dimensional world. Stereopsis is important for a number of everyday visual tasks, including (but not limited to) reaching and grasping, fine visuo-motor control, and navigating in our world. This lecture will review the neural substrate for normal binocular vision and stereopsis and its development in primates; outline some of the issues and limitations of stereopsis tests and examine some of the factors that limit the typical development of stereopsis and the causes and consequences of stereo-deficiency and stereo-blindness. Dr. Levi will review several approaches to improving or recovering stereopsis in neurotypical individuals.

Tackling Parkinson’s Disease With Basic Science

Randy Schekman, PhD

2013 Nobel Laureate in Physiology or Medicine
Cell and Developmental Biology, University of California, Berkeley

COPE Course 85482-SD: In this lecture, Dr. Schekman will focus on Parkinson’s Disease with an emphasis on how basic science is being deployed to understand the molecular and cellular basis of the disease. He will share current knowledge of the molecules and cellular organelles that form the basis of certain genetic forms of Parkinson’s Disease and explain how a new effort, “Aligning Science Across Parkinson’s Disease,” seeks to mobilize an international collaborative research network to accelerate discovery in order to identify new targets for therapeutic intervention.

Clinical Presentation: Parkinson’s Disease for the OD

Debora Lee Chen, OD, MPH, FAAO

Co-Chief, Binocular Vision Clinic
Herbert Wertheim School of Optometry and Vision Science

Jennifer Fisher, OD, FAAO

Co-Chief, Binocular Vision Clinic
Herbert Wertheim School of Optometry and Vision Science

COPE Course 85439-NO: This course discusses clinically-relevant ocular manifestations of Parkinson’s Disease. Cases highlight how optometrists are integral in helping identify the condition, and how to use optometric tools to improve the quality of life of Parkinson’s patients. You will learn how to identify common ocular manifestations of Parkinson’s Disease, select which optometric tests to administer in evaluation of patients with Parkinson’s Disease, and understand helpful optometric management tools that will enhance patients’ activities of daily living.

Panel Discussion

Chaired and moderated by John Flanagan, PhD, DSc, FCOptom
Dean, Herbert Wertheim School of Optometry and Vision Science

Glaucoma as a Neurodegenerative Disease

Yvonne Ou, MD

Ophthalmologist and Glaucoma Specialist
University of California, San Francisco

COPE Course 85573-GL: In this course, Dr. Ou will discuss glaucoma from the perspective of a neurodegenerative disease, including pathological mechanisms and neuroprotective treatment strategies. Attendees will learn to understand glaucoma from the perspective of a neurodegenerative disease, including shared features with other neurodegenerative diseases of the CNS, gain an up-to-date scientific understanding of neurodegenerative processes in the glaucomatous retina and optic nerve, and learn about neuroprotective and neuroregenerative treatment strategies that are under study or in the pipeline.

What We Know About Alzheimer’s Disease

Shane Liddelow, PhD

Neuroscience and Physiology & Ophthalmology
New York University

COPE Course 85438-NO: This course will discuss the role of astrocyte functions in maintaining brain health during normal physiology and during multiple neurodegenerative diseases and other pathological conditions. Dr. Liddelow will provide special focus on the multiple roles of reactive astrocyte phenotypes that are common across different disease states. You will learn to understand the role of astrocytes in neurodegenerative diseases, investigate the impact of astrocyte dysfunction on disease progression, evaluate astrocyte-mediated mechanisms of neuroprotection and neurotoxicity, examine the molecular and cellular alterations in astrocytes in neurodegenerative diseases, and explore therapeutic strategies targeting astrocytes for neurodegenerative diseases.

Clinical Presentation: Alzheimer’s Disease for the OD

Debora Lee Chen, OD, MPH, FAAO

Co-Chief, Binocular Vision Clinic
Herbert Wertheim School of Optometry and Vision Science

Jennifer Fisher, OD, FAAO

Co-Chief, Binocular Vision Clinic
Herbert Wertheim School of Optometry and Vision Science

COPE Course 85438-NO: This course discusses the primary care optometrist’s role in the evaluation and management of patients with Alzheimer’s disease (AD) and related dementias. Cases highlight exam modifications, helpful ancillary tests, and specific management considerations. You will be able to identify common ocular manifestations of Alzheimer’s disease and other dementias, select which optometric tests to administer in evaluation in patients with Alzheimer’s disease and dementias, and understand helpful optometric management tools that will enhance patients’ activities of daily living.

Panel Discussion

Chaired and moderated by John Flanagan, PhD, DSc, FCOptom
Dean, Herbert Wertheim School of Optometry and Vision Science

An Immunologist’s View of Neurodegenerative Disease

Karsten Gronert, MS, PhD

Molecular & Cell Biology
Herbert Wertheim School of Optometry and Vision Science

COPE Course 86135-NO: This lecture will cover regulation of immune cells and macroglia in retinal homeostasis and neurodegeneration by resident lipid
mediator pathways.

Commonalities & Differences: What Can We Learn?

Shane Liddelow, PhD

Neuroscience and Physiology & Ophthalmology
New York University

COPE Course 86262-NO: This lecture will explore the crucial role of astrocytes in health and across different neurodegenerative diseases in the eye and the rest of the CNS. Discover how astrocytes impact brain health and serve as a potential therapeutic target.

Panel Discussion

Chaired and moderated by John Flanagan, PhD, DSc, FCOptom
Dean, Herbert Wertheim School of Optometry and Vision Science

Saturday, September 23, 2023
COPE Activity #126751

Low-Dose Atropine for Myopia Control (TPA)
COPE Course 85504-GO
1 CE Hour

Translational Studies in Ocular Biomechanics: From Theory to Practice (MISC)
COPE Course 86089-TD
1 CE Hour

Updates in Ocular Surface Disease (TPA)
COPE Course 86088-TD
1 CE Hour

Alumni Grand Rounds (TPA)
COPE Course 86090-TD
2 CE Hours

Bridging the Divide in Low Vision Rehabilitation – Leveraging Telehealth for New Models of Care (MISC)
COPE Course 85570-LV
1 CE Hour

Learning to See in 3D (MISC)
COPE Course 85293-FV
1 CE Hour

Sunday, September 24, 2023
COPE Activity #126686

Tackling Parkinson’s Disease With Basic Science (MISC)
COPE Course 85482-SD
1 CE Hour

Parkinson’s Disease for the OD & Panel Discussion (MISC)
COPE Course 85439-NO
1 CE Hour

Glaucoma as a Neurodegenerative Disease (GLC)
COPE Course 85573-GL
1 CE Hour

What We Know About Alzheimer’s Disease (MISC)
COPE Course 86263-NO
1 CE Hour

Alzheimer’s Disease for the OD & Panel Discussion (MISC)
COPE Course 85438-NO
1 CE Hour

An Immunologist’s View of Neurodegenerative Disease (TPA)
COPE Course 86135-NO
0.5 CE Hour

Neurodegenerative Disease & The Eye – Commonalities and Differences: What Can We Learn (GLC)
86262-NO
0.5 CE Hour

*Total CE hours subject to change